Skip to main content
Aprogen, Inc logo

Aprogen, Inc — Investor Relations & Filings

Ticker · 007460 ISIN · KR7007460009 KO Manufacturing
Filings indexed 735 across all filing types
Latest filing 2022-09-16 Major Shareholding Noti…
Country KR South Korea
Listing KO 007460

Aprogen, Inc. is a biopharmaceutical company focused on the research, development, and manufacturing of biologic medicines. The company's core activities are centered on developing both biosimilars and novel drugs, including new protein therapeutics and bispecific antibodies. Its product development is based on proprietary technologies in antibody engineering and recombinant protein engineering.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership, including convertible bond acquisitions, by major shareholders and special related parties. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2022-09-16 Korean
조회공시요구(풍문또는보도)에대한답변(미확정)
Share Issue/Capital Change Classification · 100% confidence The document is a response to a regulatory inquiry (조회공시 요구) regarding market rumors about a potential sale and capital increase (third-party allocation). It is a standard regulatory disclosure filed with the exchange to address market speculation. Since it does not fit into specific categories like M&A (as it is a response to a rumor/inquiry) or capital change (as it is a status update on a potential, not finalized, event), it falls under the general regulatory filing category.
2022-09-16 Korean
유상증자또는주식관련사채등의발행결과(자율공시)
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) system regarding the 'Result of Issuance' for convertible bonds (a type of stock-related debt). It confirms the completion of payment for the 25th series of private convertible bonds. Since this document details the outcome of a capital-raising activity (financing) rather than just an announcement of a report or a share buyback, it falls under the 'Capital/Financing Update' category.
2022-09-15 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) regarding the issuance of convertible bonds (전환사채권 발행결정) by Aprogen. It details specific amendments (정정신고) to the terms of the bond issuance, such as the total amount, interest rates, conversion prices, and the list of investors. This type of regulatory filing, which details changes to capital structure and financing instruments, falls under the 'Capital/Financing Update' category.
2022-09-14 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders and special related parties, including specific transaction dates, share counts, and collateral agreements. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2022-09-01 Korean
조회공시요구(풍문또는보도)
Regulatory Filings Classification · 100% confidence The document is a formal request from a regulatory body (exchange) to the company (Aprogen) to clarify rumors or media reports regarding a potential sale via third-party capital increase. This is a standard regulatory inquiry/announcement issued by an exchange, which does not fit into specific categories like M&A or Capital updates, making it a general regulatory filing.
2022-08-17 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.